drugset / Trial / NCT06964568
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
RandomizedParallel-groupOpen-labelTreatment
Summary
The goal of this clinical trial is to learn if concurrent chemoradiotherapy followed by immunotherapy as maintenance therapy works to treat locally advanced esophageal squamous cell cancer in adults.
Timeline
- Start
- 2025-02-01
- Primary completion
- 2029-02
- Completion
- 2031-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Cisplatin | Other / unclassified | 25 mg/m2 | — |
| Background | Paclitaxel | Small molecule | 135 mg/m2 | — |